2026-08-26
Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth
Viva Biotech will continue to strengthen its one-stop, AI-driven novel drug R&D platform and manufacturing service platform.